Social adversity is tied to measurable brain differences across the schizophrenia spectrum
A large systematic review in JAMA Psychiatry connects adverse social determinants of health to neurobiological changes across the schizophrenia course, strengthening the case that structural disadvantage can leave a detectable imprint on the brain. The review examined whether early life adversity, social disconnection, racism and discrimination, poverty, and food insecurity were associated with alterations in brain structure, function, neurochemistry, or plasticity in people with or at risk for schizophrenia-spectrum psychotic conditions.
The central finding is blunt. Social exposure was not just a psychosocial correlate of illness severity; it tracked with brain differences that plausibly map onto psychosis vulnerability, symptom burden, and long-term outcome.
Fourteen thousand records narrowed to 114 studies
Investigators searched PsycInfo, PubMed, and Web of Science from database inception through January 2026 and screened 14,500 articles. Only 114 met full inclusion criteria, reflecting how sparse this area remains despite its clinical importance. Across those studies, 10,921 participants were represented, spanning the schizophrenia spectrum from high schizotypy and familial high-risk cohorts to clinical high-risk states, first-episode psychosis, recent-onset psychosis, and chronic schizophrenia.
The distribution of social exposures was heavily weighted toward early adversity. Ninety-five articles examined early life adversity, while 13 focused on social disconnection, four on racism or discrimination, two on poverty, and one on food insecurity. This imbalance matters because it means the literature still leans toward childhood stressors, even though adult structural deprivation and exclusion also shape psychosis risk and recovery.
The review also showed a strong emphasis on brain structure. Eighty-three articles reported structural measures, 23 evaluated function, 10 assessed neurochemistry, and none examined neuroplasticity directly. The gap is striking: the field has gathered substantial observational evidence of altered circuitry, but it has barely begun to map how social adversity may influence plasticity mechanisms over time.
Cortical thinning, volume loss, and weaker connectivity recur across studies
Across the included literature, greater exposure to adverse social conditions was associated with a pattern of neurobiological abnormalities. These included cortical thinning, regional brain volume reduction, decreased structural connectivity, diminished functional activation, and abnormal neurochemical levels. The review did not present a single mechanistic pathway, but the convergence across modalities is clinically meaningful because it suggests that social adversity is linked to both macrostructural and systems-level brain differences.
The biological plausibility is straightforward. Chronic stress, heightened threat vigilance, unstable housing, food insecurity, and repeated discrimination can all sustain inflammatory and neuroendocrine activation. Over time, those exposures may interfere with synaptic maintenance, myelination, and network integration during vulnerable developmental windows. In schizophrenia-spectrum illness, where neurodevelopmental risk is already elevated, these external pressures may push an already fragile system toward more pronounced dysfunction.
One finding deserves emphasis in plain language: the studies did not merely show emotional distress associated with worse symptoms. They repeatedly pointed to altered brain organization itself.
Early adversity dominated the evidence, but the other exposures were not benign
Early life adversity accounted for the vast majority of included studies, and that concentration likely reflects the ease of measuring childhood trauma compared with more complex structural exposures. Yet the smaller bodies of work on social disconnection, racism and discrimination, poverty, and food insecurity all fit the same broad pattern. Each of these exposures can intensify isolation, reduce access to care, impair sleep, and increase allostatic load, any of which may worsen psychosis risk and complicate recovery.
Social disconnection is especially relevant in schizophrenia-spectrum disorders because the illness itself can reduce social participation, while exclusion and loneliness can further magnify negative symptoms and cognitive strain. Racism and discrimination may act through repeated social threat, anticipatory vigilance, and restricted opportunity, embedding stress at both psychological and biological levels. Poverty and food insecurity add an additional layer by shaping medication access, treatment adherence, metabolic risk, and the brain’s capacity to recover from prior injury.
The review’s evidence base was too heterogeneous to collapse into a single causal estimate, but the direction of travel was consistent enough to support a coherent interpretation: social adversity and neurobiology are intertwined throughout the course of psychotic illness.
Neuroscience and social epidemiology are converging on the same problem
The most important implication is not abstract. If adverse social conditions are associated with measurable brain abnormalities, then psychosis prevention cannot remain confined to clinic-based symptom management. Screening for social risk, reducing exposure to deprivation, and addressing discrimination become part of a biologically informed strategy, not just a moral or policy preference.
For clinicians, the review reinforces a practical reality: patients with schizophrenia-spectrum disorders often carry layered exposures that affect prognosis before the first psychiatric contact. Earlier onset, greater symptom severity, and poorer long-term outcomes may reflect not only illness biology but also the cumulative effects of unstable environments. Treatment plans that ignore those exposures risk underestimating the forces driving relapse, disengagement, and functional decline.
The review also points to a research opportunity. Future work will need to move beyond cross-sectional associations toward longitudinal designs that can separate cause from consequence, identify sensitive developmental periods, and test whether intervention on social conditions alters brain trajectories. Neuroplasticity, in particular, remains largely unmapped in this literature. Without that evidence, the field can describe embedded disadvantage, but it cannot yet show how reversible those changes may be.
For now, the evidence supports a clear conclusion: social adversity and schizophrenia biology are not separate stories. They are overlapping parts of the same disease course, and the brain appears to register that overlap in structure, function, and chemistry.